GlassScriptPhysician profile
Michael J Petrocelli
NPI 1811988165
$10,521.88
in general payments reported to CMS, 2019-2025
27 companies · $502 in 2025
The $502 reported for 2025 was more than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,335 · 2020: $105 · 2021: $252 · 2022: $665 · 2023: $785 · 2024: $2,878 · 2025: $502.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,341 · Consulting Fee: $824.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,340.65 |
| Consulting Fee | $824.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organogenesis INC. | $4,926.98 | 2019-2025 | Cygnus Dual, Simplimax, Puraply |
| Reprise Biomedical, INC. | $2,387.53 | 2023-2025 | Miro3d, Miro3d Fibers, Miroderm |
| Kci USA, INC. | $1,123.29 | 2019-2023 | Activ.A.C., Promogran Prisma, Prevena |
| Smith+Nephew, INC. | $353.73 | 2020-2024 | Collagenase Santyl, Regranex, Grafix Pl |
| Aroa Biosurgery Incorporated | $333.57 | 2024 | |
| Nevro Corp. | $293.00 | 2023-2024 | Senza |
| Wright Medical Technology, INC. | $182.23 | 2019-2020 | |
| Stryker Corporation | $156.71 | 2019-2025 | Easyfuse |
| Biocomposites INC | $118.37 | 2019 | |
| Convatec INC. | $92.45 | 2023-2025 | |
| Treace Medical Concepts, INC. | $67.00 | 2023-2024 | |
| Depuy Synthes Sales INC. | $52.02 | 2023-2024 | Motoband, Hammerlock |
| Globus Medical, INC. | $50.31 | 2025 | Senza |
| Cashflow Solutions, LLC | $49.48 | 2022-2025 | Pcd-51 731a (US) - White, Pcd-52 737a (US) White, Lympha Press Optimal Plus(US) Bt |
| Medtronic, INC. | $39.32 | 2023 | Intellis Adaptivestim |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Djo, LLC | $38.52 | 2019-2025 | Cmf |
| Next Science LLC | $37.57 | 2023-2024 | Xperience, Surgx, Blastx |
| Kerecis Limited | $28.75 | 2019 | |
| Triad Life Sciences INC. | $27.14 | 2022 | |
| Hydrofera LLC | $24.13 | 2022 | |
| Arthrex, INC. | $24.00 | 2023 | |
| Solventum Corporation | $23.26 | 2025 | Activ.A.C. |
| Hartmann USA, INC. | $22.76 | 2025 | Zetuvit Plus 10x10 P10 |
| Melinta Therapeutics, LLC | $21.39 | 2019 | |
| Averitas Pharma INC. | $19.87 | 2025 | Qutenza |
| Medline Industries LP | $14.91 | 2019 | |
| Horizon Therapeutics Plc | $13.59 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Petrocelli listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.